Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Sign Up to like & getrecommendations! Published in 2020 at "Leukemia research"
DOI: 10.1016/j.leukres.2020.106402
Abstract: INTRODUCTION Chromosome 17 abnormalities, especially disorders of the 17p region and including TP53 gene mutations, result in very low rates of cure for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) treated with… read more here.
Keywords: aml mds; chromosome abnormalities; myeloid leukemia; hct ... See more keywords